U
Avivagen Inc. VIVXF
$0.00 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2023 04/30/2023 01/31/2023 10/31/2022 07/31/2022
Net Income 23.91% -7.36% 12.91% 33.49% -43.62%
Total Depreciation and Amortization -64.60% -25.17% -1.31% -3.16% -1.86%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -14.72% 75.66% -46.34% 35.29% 93.54%
Change in Net Operating Assets -27.10% 2.06% 848.07% -129.88% 15.65%
Cash from Operations 26.42% 143.85% 82.43% 38.06% -38.60%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- 100.00% -200.00%
Total Debt Repaid 139.32% -2.18% -77.52% 97.65% 89.80%
Issuance of Common Stock -100.00% -- -- -84.01% 31.26%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -9.69% 33.90% -75.20% -104.54% 384.75%
Cash from Financing -7.66% 50.00% -124.97% 203.98% -88.66%
Foreign Exchange rate Adjustments -200.00% 0.00% 133.33% -118.18% 512.50%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 100.00% 96.42% -27.49% 79.65% -247.63%